New Delhi, July 28 -- The Supreme Court on Monday dismissed Sun Pharma Laboratories' appeal against a Delhi High Court judgment permitting Ahmedabad-based Intas Pharmaceuticals to manufacture and market its anti-cancer drug under the trademark 'Bevatas', saying that there was no likelihood of confusion with Sun Pharma's registered trademark 'Bevetex'. A bench headed by Chief Justice of India Surya Kant and comprising justices Joymalya Bagchi and V Mohana affirmed the high court's finding that the rival marks did not create a likelihood of confusion among the relevant class of consumers, including oncologists, chemists, trained nurses, patients and their attendants. The bench also agreed with the high court that the two medicines were not th...